Medigene Takes Center Stage In Roivant's Latest 'Vant'

Germany - China
Medigene of Germany's cell therapies to be developed for China through Cytovant deal • Source: Shutterstock
Scrip Podcast

Keep up with the top pharma business news of the week. On the go.

Scrip brings you a weekly bulletin of top picks.

More from China

More from Focus On Asia